PART1 and liver cancer: Therefore, the present study aimed to investigate the potential role of lncRNA PART1 and its expression pattern in regulating the occurrence and development of liver cancer through miR-3529-3p by targeting the FOXC2-mediated Akt signalling pathway in Hep3B cells.